$XLV going to outperform $SPY (5/5)

Conviction: 5/5
Health Care (XLV) is looking very attractive relative to S&P 500 (SPY), just bounced off of long-term (2022) support on a relative basis.

RSI-M at oversold levels (obviously), while RSI-W seems to have put in a bullish divergence?

Let's see which channel wins, but I think long-term one is stronger.